Children in England and Wales Diagnosed with Common Paediatric Brain Tumour now Have Access to New Treatment
Novartis have announced that the National Institute for Health and Care Excellence has published its Final Draft Guidance (FDG) recommending the combination therapy of dabrafenib with trametinib, within its marketing authorisation, as an option for …